CoreX Peptides
IGF1-LR3
IGF1-LR3
Couldn't load pickup availability
IGF-LR3 (Insulin-like Growth Factor 1, Long Arg3) is a research-grade synthetic analogue of human IGF-1 modified with a 13-amino-acid N-terminal extension and an arginine substitution at position 3. These two modifications dramatically reduce affinity for IGF-binding proteins (IGFBPs), extending its functional half-life and increasing receptor availability in research settings. It is one of the most extensively studied IGF-1 analogues in cellular proliferation and anabolic signalling research.
Available in 1mg vials
RESEARCH APPLICATIONS INCLUDE:
- Cellular proliferation and myoblast differentiation studies
- IGF-1 receptor binding kinetics and downstream PI3K/Akt signalling
- Glucose uptake and insulin sensitivity pathway research
- Muscle protein synthesis and anti-catabolic mechanism investigation
- Comparative research vs native IGF-1 and other growth factor analogues
- mTOR pathway activation and cellular growth signalling studies
PRODUCT SPECIFICATIONS:
- Form: Lyophilised powder
- Purity: ≥99%
- Storage: −20°C, protected from light and moisture
- Available strength: 1mg
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use
Share
